CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹26,711 Cr | ₹22,179 Cr | ₹18,471 Cr | ₹16,054 Cr | ₹13,523 Cr |
What is the latest Appropriations of CIPLA ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹26,711 Cr |
| Mar2025 | ₹22,179 Cr |
| Mar2024 | ₹18,471 Cr |
| Mar2023 | ₹16,054 Cr |
| Mar2022 | ₹13,523 Cr |
How is Appropriations of CIPLA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹26,711 Cr | 20.44 | |
| Mar2025 | ₹22,179 Cr | 20.07 | |
| Mar2024 | ₹18,471 Cr | 15.06 | |
| Mar2023 | ₹16,054 Cr | 18.72 | |
| Mar2022 | ₹13,523 Cr | - | |
Compare Appropriations of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,354.8 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹105,169.0 Cr | -2% | 2.7% | 7.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2.7% |
2.5% |
-4% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses